Safety of high-intensity corneal collagen crosslinking
Safety of high-intensity corneal collagen crosslinking
复制标题
DOI:
10.1016/j.jcrs.2013.11.041
复制
发表时间:
2014-08-01
影响因子:
2.8
通讯作者:
Pallikaris, Aristophanis I.
中科院分区:
文献类型:
--
作者:
Kymionis, George D.;Grentzelos, Michael A.;Pallikaris, Aristophanis I.
PURPOSE: To evaluate the safety of a new high-intensity corneal collagen crosslinking (CXL) treatment protocol for keratoconus.SETTING: Vardinoyiannion Eye Institute of Crete, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece.DESIGN: Prospective interventional case series.METHODS: Patients with progressive keratoconus had CXL using a new treatment protocol with 9 mW/cm(2) irradiance for duration of 10 minutes. The rate of reepithelialization, endothelial cell density (ECD), corrected distance visual acuity (CDVA), and steep and flat keratometry (K) values were evaluated preoperatively and 3 months postoperatively.RESULTS: Nine patients (10 eyes) were enrolled. No intraoperative or early postoperative complications were observed in any patient. The ECD did not change significantly 3 months postoperatively (P=.169). The CDVA improved from 0.19 logMAR +/- 0.20 (SD) preoperatively to 0.10 +/- 0.16 logMAR 3 months postoperatively; however, the improvement did not attain significance (P=.141). No eye lost lines of CDVA. The mean steep K readings decreased significantly from 48.04 +/- 2.57 diopters (D) preoperatively to 46.51 +/- 2.81 D 3 months postoperatively (P=.047); the mean flat K readings did not change significantly postoperatively (P=.285).CONCLUSIONS: Corneal collagen crosslinking at 9 mW/cm(2) irradiance for 10 minutes did not cause significant changes in ECD or intraoperative or early postoperative complications. None patient lost a line of CDVA 3 months after the procedure.